Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights several positive aspects: a partnership with AWS, a 13% dividend increase, and strong free cash flow. Although there are regulatory uncertainties and elongated client conversations, these are normalizing. The Q&A reveals optimism in digital asset opportunities and capital market tech growth. Despite some unclear responses, the overall sentiment is positive, with strong financial performance and strategic initiatives supporting a positive stock price movement.
Net Revenue $1.3 billion, a year-over-year increase of 12%. The increase was driven by new and existing clients, product innovation, higher valuations in Nasdaq indices, and higher overall volumes in Market Services.
Solutions Revenue $991 million, representing 10% year-over-year growth. Growth was attributed to strong demand for financial technology solutions and product innovation.
Annualized Recurring Revenue (ARR) $2.9 billion, a 9% year-over-year growth. Growth was driven by strong demand for SaaS and financial technology solutions.
Operating Income $721 million, a 16% year-over-year increase. The increase was driven by revenue growth and controlled expense growth.
Earnings Per Share (EPS) 24% growth year-over-year. This was driven by strong revenue performance and operating leverage.
Capital Access Platforms Revenue $527 million, a 9% year-over-year growth. Growth was driven by data and listings revenue, index revenue, and analytics.
Financial Technology Revenue $464 million, a 10% year-over-year growth. Growth was driven by demand for financial crime management technology, regulatory technology, and capital markets technology.
Market Services Revenue $306 million, a 21% year-over-year growth. Growth was driven by record net revenue in U.S. options and U.S. cash equities, higher share, and higher capture in U.S. options.
Operating Expense $585 million, an increase of just under 8% year-over-year. The increase was due to investments in technology, employee compensation, and inflation.
Free Cash Flow $467 million in the second quarter. This enabled the company to support deleveraging, dividends, and share repurchases.
Agentic AI workforce: Launched by Nasdaq Verafin, this suite of digital workers aims to enhance compliance effectiveness and efficiency. Early results show an 80% reduction in alert review workload for banks.
Drug trafficking analytics: Launched in early beta, this product has already driven strong client engagement.
Digital assets innovation: Nasdaq Calypso announced a proof of concept to integrate on-chain capabilities for dynamic collateral management, targeting a launch in 2026.
IPO performance: Nasdaq welcomed 38 new operating companies in Q2, raising $3.6 billion. Year-to-date, 83 companies were listed, including 3 of the top 5 largest IPOs, with an 81% win rate.
European listings: Nasdaq exchanges in Europe saw 10 new listings year-to-date, raising EUR 2 billion, a fivefold increase compared to the first half of 2024.
Revenue growth: Net revenue increased by 12% year-over-year to $1.3 billion, with solutions revenue growing by 10%.
Efficiency program: Actioned $130 million out of a $140 million net expense efficiency program by the end of Q2.
Adenza acquisition: Achieved a gross leverage ratio of 3.2x, surpassing milestones set at the acquisition 16 months ahead of schedule.
Cross-sell strategy: Generated 7 cross-sell wins in Q2, with cross-sells accounting for over 15% of the Financial Technology sales pipeline.
Macroeconomic Uncertainty: Persistent macroeconomic uncertainty, including muted GDP growth in Europe and unclear long-term impacts of trade and economic policies, could impact client demand and overall business performance.
Regulatory Environment: Uncertainty around regulatory changes, such as the supplementary leverage ratio in the U.S., has caused delays in client readiness and professional services revenue growth.
Market Volatility: Heightened market volatility, while providing some opportunities, also poses risks to consistent revenue generation and operational stability.
Client Readiness Delays: Delays in client readiness, particularly in Regulatory Technology and Financial Technology segments, have impacted professional services revenue and could delay revenue realization.
Economic Conditions in Europe: Muted GDP growth and slow recovery in consumer demand in Europe could affect the company's European operations and revenue growth.
Competitive Pressures: The need to maintain a competitive edge through innovation and technology investments could strain resources and impact margins.
Supply Chain and Operational Risks: Complexity in financial institutions' landscapes and operational challenges in delivering mission-critical technologies could impact execution and client satisfaction.
Currency Exchange Risks: Movements in foreign exchange rates have impacted financial results, including a $20 million increase in expense guidance due to FX.
IPO Outlook: Optimism on the IPO outlook for the remainder of 2025 and into 2026, driven by strong performance of recent listings and a robust pipeline.
Private Market Solutions: Focus on meeting growing demand for private market solutions, with new partnerships and client signings building momentum.
Financial Technology Growth: Continued growth expected across products, client segments, and geographies, supported by strong sales execution and demand for mission-critical technologies.
Regulatory Technology: Improved clarity around the regulatory environment in the U.S. expected to strengthen the pipeline and professional services revenue starting in Q4 2025 and early 2026.
Capital Markets Technology: Strong demand expected for technology infrastructure solutions and operational expertise, with a solid pipeline for the rest of 2025.
AI and Digital Assets Innovation: Nasdaq Verafin's Agentic AI workforce and digital asset initiatives targeting launch in early to mid-2026, focusing on compliance efficiency and institutional adoption.
Cross-Sell Revenue: On track to surpass $100 million in run rate revenue from cross-sells by the end of 2027, with cross-sells accounting for over 15% of the Financial Technology sales pipeline.
Expense Efficiency Program: Expanded $140 million net expense efficiency program expected to be actioned by year-end 2025.
Revenue Growth Outlook: 2025 revenue growth outlook for divisions and subdivisions expected to remain consistent with prior guidance.
Capital Allocation: Continued focus on organic investments, dividends, and opportunistic debt and share repurchases to support long-term growth.
Dividend Payment: Nasdaq paid a dividend of $0.27 per share, totaling $155 million in the quarter. This represents a 34% annualized payout ratio.
Share Repurchase: Nasdaq repurchased a total of 1.2 million shares of its common stock for approximately $100 million in the second quarter. This included the completion of annual employee dilution-related repurchases and additional opportunistic repurchases.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.